Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113806252 | 11380625 | 2 | F | 2007 | 20160720 | 20150814 | 20160907 | PER | US-JNJFOC-20150723530 | JANSSEN | 0.00 | A | F | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113806252 | 11380625 | 1 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 0 | 500 | MG | TABLETS | ||||||
| 113806252 | 11380625 | 2 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 0 | 750 | MG | TABLETS | ||||||
| 113806252 | 11380625 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 0 | 750 | MG | TABLETS | ||||||
| 113806252 | 11380625 | 4 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | U | U | 20634 | 500 | MG | TABLETS | ||||||
| 113806252 | 11380625 | 5 | SS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | U | 0 | 400 | MG | TABLETS | |||||||
| 113806252 | 11380625 | 6 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | U | 0 | 500 | MG | TABLET | |||||||
| 113806252 | 11380625 | 7 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | U | 0 | 250 | MG | TABLET | |||||||
| 113806252 | 11380625 | 8 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | U | 0 | 250 | MG | TABLET | |||||||
| 113806252 | 11380625 | 9 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | U | 0 | 500 | MG | TABLET | |||||||
| 113806252 | 11380625 | 10 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | 30 | MG | UNSPECIFIED | QD | |||||||
| 113806252 | 11380625 | 11 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | 0 | 10 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113806252 | 11380625 | 1 | Bronchitis |
| 113806252 | 11380625 | 2 | Bronchitis |
| 113806252 | 11380625 | 3 | Bronchitis |
| 113806252 | 11380625 | 4 | Bronchitis |
| 113806252 | 11380625 | 5 | Bronchitis |
| 113806252 | 11380625 | 6 | Bronchitis |
| 113806252 | 11380625 | 7 | Bronchitis |
| 113806252 | 11380625 | 8 | Bronchitis |
| 113806252 | 11380625 | 9 | Bronchitis |
| 113806252 | 11380625 | 10 | Fibromyalgia |
| 113806252 | 11380625 | 11 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113806252 | 11380625 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113806252 | 11380625 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113806252 | 11380625 | 1 | 20080719 | 20080730 | 0 | |
| 113806252 | 11380625 | 2 | 20080229 | 20080310 | 0 | |
| 113806252 | 11380625 | 3 | 20070428 | 20070505 | 0 | |
| 113806252 | 11380625 | 4 | 20140522 | 20140526 | 0 | |
| 113806252 | 11380625 | 5 | 20070613 | 0 | ||
| 113806252 | 11380625 | 6 | 20070214 | 20070218 | 0 | |
| 113806252 | 11380625 | 7 | 20131216 | 20131218 | 0 | |
| 113806252 | 11380625 | 8 | 20071120 | 20071206 | 0 | |
| 113806252 | 11380625 | 9 | 20040209 | 20040214 | 0 | |
| 113806252 | 11380625 | 10 | 2007 | 2013 | 0 | |
| 113806252 | 11380625 | 11 | 2006 | 2007 | 0 |